Overbought Stocks
ASST appears in our Overbought Stocks screen, meaning it has experienced strong recent gains and may be trading at extended levels that could lead to short-term consolidation or pullback.
NASDAQ:ASST • US8629453007
The current stock price of ASST is 16.66 USD. Today ASST is up by 8.82%. In the past month the price increased by 67.77%. In the past year, price increased by 39.11%.
ASST currently appears in the following ChartMill screener lists.
ASST appears in our Overbought Stocks screen, meaning it has experienced strong recent gains and may be trading at extended levels that could lead to short-term consolidation or pullback.
ASST is RSI overbought, meaning strong buying pressure may lead to a short-term consolidation or pullback.
ChartMill assigns a technical rating of 5 / 10 to ASST. When comparing the yearly performance of all stocks, ASST is one of the better performing stocks in the market, outperforming 71.98% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to ASST. ASST has a great financial health rating, but its profitability evaluates not so good.
8 analysts have analysed ASST and the average price target is 16.32 USD. This implies a price decrease of -2.04% is expected in the next year compared to the current price of 16.66.
For the next year, analysts expect an EPS growth of 95.89% and a revenue growth 294.91% for ASST
Over the last trailing twelve months ASST reported a non-GAAP Earnings per Share(EPS) of -14.04. The EPS increased by 61.24% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -48.64% | ||
| ROE | -49.59% | ||
| Debt/Equity | 0 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 41.46 | 171.767B | ||
| ABT | ABBOTT LABORATORIES | 14.59 | 159.344B | ||
| SYK | STRYKER CORP | 21.78 | 126.134B | ||
| BSX | BOSTON SCIENTIFIC CORP | 16.43 | 96.409B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.06 | 47.005B | ||
| IDXX | IDEXX LABORATORIES INC | 39.06 | 45.933B | ||
| BDX | BECTON DICKINSON AND CO | 11.4 | 44.32B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.81 | 32.57B | ||
| RMD | RESMED INC | 18.08 | 32.347B | ||
| DXCM | DEXCOM INC | 24.93 | 24.404B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.97 | 18.01B | ||
| PODD | INSULET CORP | 29.86 | 13.41B | ||
| PEN | PENUMBRA INC | 65.18 | 13.063B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Strive Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Dallas, Texas and currently employs 9 full-time employees. The company went IPO on 2023-02-03. Strive, Inc. is an asset management Bitcoin treasury company. The firm is focused on increasing Bitcoin per share to outperform Bitcoin over the long run. The firm's subsidiary, Strive Asset Management, LLC, is a SEC-registered investment adviser, which has assets under management (AUM) across approximately 13 exchange-traded funds, collective investment trusts, and a direct indexing platform. In addition, the Company owns Semler Scientific, Inc., a healthcare technology subsidiary focused on early disease detection products. Through its healthcare businesses, Semler Scientific and its wholly-owned subsidiary, CardioVanta, Inc. develop and market products and services for early detection and monitoring of chronic diseases. Semler Scientific's flagship product, QuantaFlo, provides rapid point-of-care testing to measure arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of peripheral arterial disease.
IPO: 2023-02-03
STRIVE INC-A
200 Crescent Ct, Suite 1400
Dallas TEXAS US
Employees: 9
Phone: 18554277360
Strive Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Dallas, Texas and currently employs 9 full-time employees. The company went IPO on 2023-02-03. Strive, Inc. is an asset management Bitcoin treasury company. The firm is focused on increasing Bitcoin per share to outperform Bitcoin over the long run. The firm's subsidiary, Strive Asset Management, LLC, is a SEC-registered investment adviser, which has assets under management (AUM) across approximately 13 exchange-traded funds, collective investment trusts, and a direct indexing platform. In addition, the Company owns Semler Scientific, Inc., a healthcare technology subsidiary focused on early disease detection products. Through its healthcare businesses, Semler Scientific and its wholly-owned subsidiary, CardioVanta, Inc. develop and market products and services for early detection and monitoring of chronic diseases. Semler Scientific's flagship product, QuantaFlo, provides rapid point-of-care testing to measure arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of peripheral arterial disease.
The current stock price of ASST is 16.66 USD. The price increased by 8.82% in the last trading session.
ASST does not pay a dividend.
ASST has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
The Revenue of STRIVE INC-A (ASST) is expected to grow by 294.91% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
STRIVE INC-A (ASST) has a market capitalization of 1.15B USD. This makes ASST a Small Cap stock.